152 related articles for article (PubMed ID: 31026220)
1. Succinate Dehydrogenase-Deficient Renal Cell Carcinoma.
Tsai TH; Lee WY
Arch Pathol Lab Med; 2019 May; 143(5):643-647. PubMed ID: 31026220
[TBL] [Abstract][Full Text] [Related]
2. Review of succinate dehydrogenase-deficient renal cell carcinoma with focus on clinical and pathobiological aspects.
Kuroda N; Yorita K; Nagasaki M; Harada Y; Ohe C; Jeruc J; Raspollini MR; Michal M; Hes O; Amin MB
Pol J Pathol; 2016 Mar; 67(1):3-7. PubMed ID: 27179267
[TBL] [Abstract][Full Text] [Related]
3. Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma.
Williamson SR; Eble JN; Amin MB; Gupta NS; Smith SC; Sholl LM; Montironi R; Hirsch MS; Hornick JL
Mod Pathol; 2015 Jan; 28(1):80-94. PubMed ID: 25034258
[TBL] [Abstract][Full Text] [Related]
4. Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients.
Gill AJ; Hes O; Papathomas T; Šedivcová M; Tan PH; Agaimy A; Andresen PA; Kedziora A; Clarkson A; Toon CW; Sioson L; Watson N; Chou A; Paik J; Clifton-Bligh RJ; Robinson BG; Benn DE; Hills K; Maclean F; Niemeijer ND; Vlatkovic L; Hartmann A; Corssmit EP; van Leenders GJ; Przybycin C; McKenney JK; Magi-Galluzzi C; Yilmaz A; Yu D; Nicoll KD; Yong JL; Sibony M; Yakirevich E; Fleming S; Chow CW; Miettinen M; Michal M; Trpkov K
Am J Surg Pathol; 2014 Dec; 38(12):1588-602. PubMed ID: 25025441
[TBL] [Abstract][Full Text] [Related]
5. Succinate dehydrogenase B-deficient renal cell carcinoma: A case report with novel germline mutation.
Iwashita H; Okudela K; Matsumura M; Yamanaka S; Sawazumi T; Enaka M; Udaka N; Miyake A; Hibiya T; Miyake N; Matsumoto N; Makiyama K; Yao M; Nagashima Y; Ohashi K
Pathol Int; 2017 Nov; 67(11):585-589. PubMed ID: 28960644
[TBL] [Abstract][Full Text] [Related]
6. Succinate Dehydrogenase-Deficient Renal Cell Carcinoma: A Short Review.
Wang G; Rao P
Arch Pathol Lab Med; 2018 Oct; 142(10):1284-1288. PubMed ID: 30281364
[TBL] [Abstract][Full Text] [Related]
7. SDH-deficient renal cell carcinoma - clinical, pathologic and genetic correlates: a case report.
Kumar R; Bonert M; Naqvi A; Zbuk K; Kapoor A
BMC Urol; 2018 Nov; 18(1):109. PubMed ID: 30482207
[TBL] [Abstract][Full Text] [Related]
8. A distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinoma.
Smith SC; Sirohi D; Ohe C; McHugh JB; Hornick JL; Kalariya J; Karia S; Snape K; Hodgson SV; Cani AK; Hovelson D; Luthringer DJ; Martignoni G; Chen YB; Tomlins SA; Mehra R; Amin MB
Histopathology; 2017 Jul; 71(1):42-52. PubMed ID: 28165631
[TBL] [Abstract][Full Text] [Related]
9. [Succinate dehydrogenase (SDH)-deficient renal cell carcinoma].
Agaimy A
Pathologe; 2016 Mar; 37(2):144-52. PubMed ID: 26979428
[TBL] [Abstract][Full Text] [Related]
10. Hereditary succinate dehydrogenase-deficient renal cell carcinoma.
Rogala J; Zhou M
Semin Diagn Pathol; 2024 Jan; 41(1):32-41. PubMed ID: 37981479
[TBL] [Abstract][Full Text] [Related]
11. Renal tumors associated with germline SDHB mutation show distinctive morphology.
Gill AJ; Pachter NS; Chou A; Young B; Clarkson A; Tucker KM; Winship IM; Earls P; Benn DE; Robinson BG; Fleming S; Clifton-Bligh RJ
Am J Surg Pathol; 2011 Oct; 35(10):1578-85. PubMed ID: 21934479
[TBL] [Abstract][Full Text] [Related]
12. Renal carcinoma associated with succinate dehydrogenase B mutation: a new and unique subtype of renal carcinoma.
Paik JY; Toon CW; Benn DE; High H; Hasovitz C; Pavlakis N; Clifton-Bligh RJ; Gill AJ
J Clin Oncol; 2014 Feb; 32(6):e10-3. PubMed ID: 24395865
[No Abstract] [Full Text] [Related]
13. SDH-deficient renal cell carcinoma: a clinicopathological analysis highlighting the role of genetic counselling.
Wilczek Y; Sachdeva A; Turner H; Veeratterapillay R
Ann R Coll Surg Engl; 2021 Jan; 103(1):e20-e22. PubMed ID: 32969237
[TBL] [Abstract][Full Text] [Related]
14. Germline SDHC mutation presenting as recurrent SDH deficient GIST and renal carcinoma.
Gill AJ; Lipton L; Taylor J; Benn DE; Richardson AL; Frydenberg M; Shapiro J; Clifton-Bligh RJ; Chow CW; Bogwitz M
Pathology; 2013 Dec; 45(7):689-91. PubMed ID: 24150194
[No Abstract] [Full Text] [Related]
15. Succinate dehydrogenase (SDH)-deficient neoplasia.
Gill AJ
Histopathology; 2018 Jan; 72(1):106-116. PubMed ID: 29239034
[TBL] [Abstract][Full Text] [Related]
16. Positive/retained SDHB immunostaining in renal cell carcinomas associated to germline SDHB-deficiency: case report.
Ugarte-Camara M; Fernandez-Prado R; Lorda I; Rossello G; Gonzalez-Enguita C; Cannata-Ortiz P; Ortiz A
Diagn Pathol; 2019 May; 14(1):42. PubMed ID: 31092265
[TBL] [Abstract][Full Text] [Related]
17. A Novel SDHA-deficient Renal Cell Carcinoma Revealed by Comprehensive Genomic Profiling.
Yakirevich E; Ali SM; Mega A; McMahon C; Brodsky AS; Ross JS; Allen J; Elvin JA; Safran H; Resnick MB
Am J Surg Pathol; 2015 Jun; 39(6):858-63. PubMed ID: 25724004
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathological characteristics of fumarate hydratase-deficient renal cell carcinoma].
Zhang W; Chu J; Zou YW; Jiang YX; Wei ZM; Zhong DC; Liu Y; Li YJ; Yu WJ
Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):120-126. PubMed ID: 30695864
[No Abstract] [Full Text] [Related]
19. Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients.
Fuchs TL; Maclean F; Turchini J; Vargas AC; Bhattarai S; Agaimy A; Hartmann A; Kao CS; Ellis C; Bonert M; Leroy X; Kunju LP; Schwartz L; Matsika A; Williamson SR; Rao P; Divatia M; Guarch R; Algaba F; Balancin ML; Zhou M; Samaratunga H; da Cunha IW; Brimo F; Ryan A; Clouston D; Aron M; O'Donnell M; Chan E; Hirsch MS; Moch H; Pang CY; Wah C; Yin W; Perry-Keene J; Yilmaz A; Chou A; Clarkson A; van der Westhuizen G; Morrison E; Zwi J; Hes O; Trpkov K; Gill AJ
Mod Pathol; 2022 Jun; 35(6):836-849. PubMed ID: 34949766
[TBL] [Abstract][Full Text] [Related]
20. Fumaratehydratase-deficient renal cell carcinoma: a clinicopathological and molecular study of 13 cases.
Pan X; Zhang M; Yao J; Zeng H; Nie L; Gong J; Chen X; Xu M; Zhou Q; Chen N
J Clin Pathol; 2019 Nov; 72(11):748-754. PubMed ID: 31262952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
